Prevalence and determinants of antibiotic resistance in faecal Escherichia coli among unselected patients attending general practitioners in Southwest Germany

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 5, 2004, Pages 303-308

  Stürmer, Til ^a   Erb, Andrea ^a   Marre, Reinhard ^b   Brenner, Hermann ^a  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Antibiotics; Bacterial infections; Drug resistance; Epidemiology; Surveillance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENERAL PRACTITIONER; GERMANY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; POPULATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; GERMANY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE;

EID: 2542585352     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.861     Document Type: Article

References (29)

1. Howard D, Scott RD, Packard R, Jones DA. The global impact of drug resistance. Clin Infect Dis 2002; 36(Suppl. 1): S4-S10.
2. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2002; 36(Suppl. 1): S11-S23.
3. Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br Med J 2000; 32: 213-216.
4. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. J Am Med Assoc 1996; 275: 300-304.
5. Murray BE. Can antibiotic resistance be controlled? New Engl J Med 1994; 330: 1229-1230.
6. de Man P, Verhoeven BAN, Verburgh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973-978.
7. Bouvenot G. L'Observatoire national des prescriptions et consommation des medicaments Prescription et consommation des antibiotiques en ambulatoire. Bull Academ Natl Med 1999; 183: 601-609.
8. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equations approach. Biometrics 1988; 44: 1049-1060.
9. Lipsitz SR, Harrington DP. Analyzing correlated binary data using SAS. Comput Biomed Res 1990; 23: 268-282.
10. Stürmer T, Glynn RJ, Kliebsch U, Brenner H. Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol 2000; 53: 57-64.
11. Reves RR, Fong M, Pickering LK, Bartlett A, Alvarez M, Murray BE. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob Agents Chemother 1990; 34: 1429-1434.
12. Fornasini M, Reves RR, Murray BE, Morrow AL, Pickering LK. Trimethoprim-resistant Escherichia coli in households of children attending day care centers. J Infect Dis 1992; 166: 326-330.
13. Reves RR, Murray BE, Pickering LK, Prado D, Maddock M, Bartlett AV. Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers. J Infect Dis 1987; 156: 758-762.
14. London N, Nijsten R, Mertens P, v d Bogaard A, Stobberingh E. Effect of antibiotic therapy on the antibiotic resistance of faecal Escherichia coli in patients attending general practitioners. J Antimicrob Chemother 1994; 34: 239-246.
15. Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. New Engl J Med 1982; 306: 130-135.
16. Horcajada JP, Vila J, Moreno-Martinez A, et al. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 2002; 49: 55-59.
17. Garau J, Xercavins M, Rodriguez-Carballeira M, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-2741.
18. Magee JT, Pritchard EL, Fitzgerald KA, Dunstan FD, Howard AJ. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. Br Med J 1999; 319: 1239-1240.
19. Frimodt-Møller N, Rosdahl N, Wegener HC. Microbiological resistance promoted by misuse of antibiotics: a public health concern. Eur J Public Health 1998; 8: 193-194.
20. Seppäla H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New Engl J Med 1997; 337: 441-446.
21. Lester SC, del Pilar Pla M, Wang F, Perez Schael I, Jiang H, O'Brien TF. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. New Engl J Med 1990; 323: 285-289.
22. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Med 1999; 14: 606-609.
23. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001; 45: 1402-1406.
24. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New Engl J Med 1994; 330: 1240-1241.
25. Sørensen TL, Blom M, Monnet DL, et al. Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. New Engl J Med 2001; 345: 1161-1166.
26. McDonald LC, Rossiter S, Mackinson C, et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. New Engl J Med 2001; 345: 1155-1160.
27. White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant Salmonella from retail ground meats. New Engl J Med 2001; 345: 1147-1154.
28. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001; 32: 1055-1061.
29. Enne VI, Livermore DM, Stephens P, Hall LMC. Persistance of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357: 1325-1328.